Bimatoprost: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Bimatoprost. Educational only — not medical advice.
Labeled uses
DURYSTA® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).
Source: FDA labeling via NIH DailyMed (set 3f59da84…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.